Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2023
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer
W Xie, P Ravi, M Buyse, et al.
Prostate Cancer and Prostatic Diseases
|
March 1, 2017
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter database
D Keizman, M O Fosboel, H Reichegger, et al.
Annals of the New York Academy of Sciences
|
October 31, 1996
Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo
M K Gately, D M Carvajal, S E Connaughton, et al.
Leukemia
|
March 30, 2025
Correction: Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials
P J Bröckelmann, H Müller, M Fuchs, et al.
Leukemia
|
March 25, 2025
Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials
P J Bröckelmann, H Müller, M Fuchs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2024
Correlation between progression-free and overall survival in patients with Hodgkin lymphoma: a comprehensive analysis of individual patient data from randomized German Hodgkin Study Group (GHSG) trials
P J Bröckelmann, H Müller, M Fuchs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2014
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
J Oldenburg, J Aparicio, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2011
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial
M Bachner, Y Loriot, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2025
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial
B Tombal, A Choudhury, F Saad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2025
Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
J Walz, G Attard, A Bjartell, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2023
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer
W Xie, P Ravi, M Buyse, et al.
Prostate Cancer and Prostatic Diseases
|
March 1, 2017
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter database
D Keizman, M O Fosboel, H Reichegger, et al.
Annals of the New York Academy of Sciences
|
October 31, 1996
Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo
M K Gately, D M Carvajal, S E Connaughton, et al.
Leukemia
|
March 30, 2025
Correction: Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials
P J Bröckelmann, H Müller, M Fuchs, et al.
Leukemia
|
March 25, 2025
Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials
P J Bröckelmann, H Müller, M Fuchs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2024
Correlation between progression-free and overall survival in patients with Hodgkin lymphoma: a comprehensive analysis of individual patient data from randomized German Hodgkin Study Group (GHSG) trials
P J Bröckelmann, H Müller, M Fuchs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2014
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
J Oldenburg, J Aparicio, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2011
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial
M Bachner, Y Loriot, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2025
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial
B Tombal, A Choudhury, F Saad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2025
Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
J Walz, G Attard, A Bjartell, et al.
Page
of 10